02219 CHAOJU EYE CARE
- 3.740
- +0.010+0.27%
CHAOJU EYE CARE News
朝聚眼科：股東週年大會通告
朝聚眼科：2023年報
Chaoju Ophthalmology (02219.HK) received ORCHID ASIA VII GLOBAL INVESTMENT LIMITED's additional common shares by 205,000 shares worth approximately HK$738,400
On April 23, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 23, ORCHID ASIA VII GLOBAL INVESTMENT LIMITED increased its share holdings of $Chaoju Ophthalmology (02219.HK) by $205,000 at an average price of HK$3.6019 per share on April 19, worth approximately HK$738,400. After the increase in holdings, ORCHID ASIA VII GLOBAL INVESTMENT LIMITED's latest shareholding number was 84.9485 million shares, and the good position ratio was 11
Chaoju Eye Care Arms Ink Five Tenancy Deals in Inner Mongolia
Chaoju Eye Care Holdings (HKG:2219) said subsidiaries Baotou City Chaoju Eye Hospital and Chaoju Medical Technology will lease three premises located in China's Inner Mongolia autonomous region from B
Several subsidiaries of Chaoju Ophthalmology (02219) signed separate lease agreements for 5 rental properties
Zhitong Finance App News, Chaoju Ophthalmology (02219) issued an announcement. On April 15, 2024, Baotou Hospital, a subsidiary of the company, signed a lease agreement I with Baotou Chaoju to lease property I for the period from April 15, 2024 to December 31, 2029. On April 15, 2024, Chaoju Medical, a subsidiary of the company, signed a lease agreement II with Baotou Chaoju to lease property II for the period from April 15, 2024 to December 31, 2029. On April 15, 2024, Chaoju Medical and Baotou Chaoju signed a lease agreement III to lease property III.
Chaoju Ophthalmology (02219.HK) obtained ORCHID ASIA VII GP, LIMITED increased its common stock holdings by 265,900, worth approximately HK$995,200
On April 15, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 15, ORCHID ASIA VII GP, LIMITED increased its share holdings of $Chaoju Ophthalmology (02219.HK) by $265,900 at an average price of HK$3,7547 per share on April 12, worth approximately HK$995,200. After the increase in holdings, ORCHID ASIA VII GP, LIMITED's latest shareholding was 77.9452 million shares, and the good position ratio increased from 10.98% to 11.02%. This transaction involves other related parties: OAV
China Post Securities: Endogenous growth is steady, and the Hong Kong stock healthcare services sector's valuation is highly attractive
Judging from the overall performance of medical service targets in Hong Kong stocks, with the exception of ICL's high revenue base in the early COVID-19 period, where dental revenue was affected by dental implant collection, most of the revenue from other medical service targets increased relatively well.
Chaoju Ophthalmology (2219.HK): Looking forward to steady revenue growth in 24 years
Incident: On March 26, 2024, the company issued an announcement. In 2023, it achieved operating income of 1369.5 million yuan, +38.3% year-on-year, and realized net profit before tax of 299.2 million yuan, +25.1% year-on-year.
Chaoju Ophthalmology (02219.HK): Strong mergers and acquisitions in basic consumer ophthalmology combine rapid expansion
Incident: On the evening of March 26, 2024, Chaoju Ophthalmology released its 2023 report. The company achieved main operating income of 1.37 billion yuan (+38.33%) and gross profit of 621 million yuan (+42.89%)
Chaoju Ophthalmology (02219.HK): Performance is basically in line with expectations, and the store network continues to expand
The 2023 results are basically in line with our expectations, Chaoju Ophthalmology announced 2023 results: revenue of 1.37 billion yuan, up 38.3% year on year; net profit to mother of 230 million yuan, up 21.9% year on year, corresponding to zero profit per share
Chaoju Eye Care Holdings Limited Just Missed EPS By 8.3%: Here's What Analysts Think Will Happen Next
It's been a good week for Chaoju Eye Care Holdings Limited (HKG:2219) shareholders, because the company has just released its latest full-year results, and the shares gained 4.8% to HK$3.93. It
Chaoju Ophthalmology (2219.HK) 2023 Annual Performance Report Review: Basic Consumer Ophthalmology Dual Growth Mergers and Acquisitions New Hospitals Dual Drivers
Incident: On March 26, 2024, the company issued an announcement. In 2023, it achieved operating income of 1.37 billion yuan, an increase of 38.33% over the previous year; realized net profit of 229 million yuan, an increase of 21.92% over the previous year.
Chaoju Ophthalmology (2219.HK): Strong growth in basic consumer ophthalmology, new hospitals continue to climb
Strong growth in basic/consumer ophthalmology, optimistic that Xinyuan will continue to climb the company's announcement to achieve 2023 revenue/net profit/adjusted net profit of 13.7/2.2/220 million yuan (up 38.3/20.5/19.8 from the previous year
CHAOJU EYE CARE To Go Ex-Dividend On June 12th, 2024 With 0.2208 HKD Dividend Per Share And 0.0767 HKD Special Dividend Per Share
March 27th - $CHAOJU EYE CARE(02219.HK)$ is trading ex-dividend on June 12th, 2024. Shareholders of record on June 13th, 2024 will receive 0.2208 HKD dividend per share and 0.0767 HKD special divi
Changes in Hong Kong stocks | Chaoju Ophthalmology (02219) increased 5% last year's net profit by 21.9% year-on-year, and endogenous epitaxial growth boosted rapid business growth
Chaoju Ophthalmology (02219) increased by 5%. As of press release, it was up 5% to HK$3.99, with a turnover of HK$11.14,900.
Chaoju Ophthalmology (02219.HK)'s annual net profit increased by 20.5% to 220 million yuan
Gelonghui, March 26, 丨 Chaoju Ophthalmology (02219.HK) announced that for the year ended December 31, 2023, the company's revenue increased by 38.3% to RMB 1,369.5 million. The Group's net profit increased by 20.5% to RMB 220.7 million. The Group's non-IFRS adjusted net profit increased 19.8% to RMB 223.1 million. The Board recommended a final dividend of HK$0.2208 per share (2022: HK$0.1738 per share) and a special dividend of HK$0.0767 per share. Number of ophthalmology hospitals operated by the Group from up to
Chaoju Ophthalmology (02219) will pay a special dividend of HK$0.0767 per share on June 28
According to Zhitong Finance App, Chaoju Ophthalmology (02219) announced that the company will pay a special dividend of HK$0.0767 per share on June 28, 2024.
Chaoju Ophthalmology (02219) announced its 2023 annual results. Shareholders should account for profit of 229 million yuan, an increase of 21.9% over the previous year
Chaoju Ophthalmology (02219) announced results for the year ended December 31, 2023, with revenue of 1,369.5 billion...
CHAOJU EYE CARE: (1) ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023; AND (2) UPDATE ON EXPECTED TIMELINE FOR THE USE OF PROCEEDS
Chaoju Eye Care Unit Invests 200 Million Yuan in Bank of China's Structured Deposit Product
A unit of Chaoju Eye Care Holdings (HKG:2219) has subscribed for 200 million yuan of structured deposit products offered by Bank of China (SHA:601988, HKG:3988), a Thursday filing on the Hong Kong bou
Analysis
Price Target
No Data
